Edition:
United Kingdom

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

68.40USD
24 Sep 2018
Change (% chg)

$-0.49 (-0.71%)
Prev Close
$68.89
Open
$68.98
Day's High
$69.09
Day's Low
$68.17
Volume
205,011
Avg. Vol
195,654
52-wk High
$72.08
52-wk Low
$44.62

Latest Key Developments (Source: Significant Developments)

Nuvasive Announces Second Quarter 2018 Financial Results
Tuesday, 31 Jul 2018 

July 31 (Reuters) - NuVasive Inc ::NUVASIVE ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.58.Q2 GAAP EARNINGS PER SHARE $0.22.Q2 REVENUE ROSE 8.5 PERCENT TO $281.6 MILLION.FULL-YEAR 2018 REVENUE GUIDANCE REMAINS IN RANGE OF $1,095 MILLION TO $1,105 MILLION.NUVASIVE - SEES 2018 NON-GAAP DILUTED EARNINGS PER SHARE IN A RANGE OF $2.37 TO $2.40.FY2018 EARNINGS PER SHARE VIEW $2.44, REVENUE VIEW $1.10 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

NuVasive Comments On Expected Impact Of U.S. Tax Reform
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Nuvasive Inc ::NUVASIVE COMMENTS ON EXPECTED IMPACT OF U.S. TAX REFORM.NUVASIVE INC - ‍SAVINGS FROM TAX REFORM EXPECTED TO BOOST FORWARD-LOOKING FREE CASH FLOW, NON-GAAP EPS IN EXCESS OF 10 % PER YEAR BEGINNING IN 2018​.NUVASIVE -EARLY ANALYSIS INDICATE NON-GAAP TAX RATE TO DROP INTO LOW 20 PERCENT RANGE IN 2018 AND IN FUTURE PERIODS CONVERGE TO 20 PERCENT NON-GAAP TAX RATE.  Full Article

Nuvasive To Acquire Safepassage
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Nuvasive Inc ::NUVASIVE TO ACQUIRE SAFEPASSAGE.NUVASIVE INC - TERMS OF DEAL WERE NOT DISCLOSED..NUVASIVE INC - NUVASIVE EXPECTS TRANSACTION TO BE ACCRETIVE TO COMPANY'S NON-GAAP EARNINGS PER SHARE (EPS) IN 2018 AND BEYOND.NUVASIVE INC - CO ALSO EXPECTS DEAL TO SUPPORT LONGER-TERM TARGETS FOR REVENUE GROWTH AND EXPANSION OF ITS NON-GAAP OPERATING AND EBITDA MARGINS.  Full Article

NuVasive announces $100 million share repurchase program
Tuesday, 24 Oct 2017 

Oct 25 (Reuters) - NuVasive Inc :NuVasive announces $100 million share repurchase program.NuVasive Inc - ‍intends to fund repurchases under share repurchase program from cash on hand, cash generated from operations​.NuVasive Inc - also ‍intends to fund repurchases from available borrowing under its existing credit facility​.  Full Article

NuVasive Inc reports Q3 GAAP earnings per share $0.64
Tuesday, 24 Oct 2017 

Oct 25 (Reuters) - NuVasive Inc :NuVasive reports third quarter 2017 financial results.Q3 non-GAAP earnings per share $0.52.Q3 GAAP earnings per share $0.64.Q3 revenue rose 3.2 percent to $247.4 million.NuVasive Inc sees ‍revenue​ and non-GAAP revenue of $1,030 million for fy 2017.NuVasive Inc sees earnings per share of $1.37 for fy 2017 and adjusted earnings per share of $1.91 for fy 2017.  Full Article

NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Nuvasive Inc ::NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology.Says ‍received expanded 510(K) clearance from U.S. FDA for co's precice system​.Says the ‍system is now indicated for bone transport of long bones in addition to limb lengthening​.  Full Article

NuVasive files lawsuit against Patrick S. Miles
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Alphatec Holdings Inc :Nuvasive files lawsuit against patrick s. Miles to protect corporate assets and stakeholders' interests.Nuvasive inc - ‍filed a lawsuit in delaware chancery court against patrick s. Miles, former vice chairman of co and member of co's board of directors​.Nuvasive inc says lawsuit asserts that ‍miles' resignation from co was "in violation of his contractual obligations to nuvasive"​.  Full Article

BRIEF-NuVasive Reports Q1 GAAP Loss Per Share Of $0.53

* FY2018 REVENUE VIEW $1.10 BILLION -- THOMSON REUTERS I/B/E/S